Skip to main content

Meridian Bioscience Gets CE Mark for CT/NG Tests, Sample Prep System

NEW YORK (GenomeWeb) – Meridian Bioscience said today that it has received the CE mark for two new Illumigene molecular diagnostic tests for Chlamydia trachomatis and Neisseria gonorrhoeae.

The new tests are the sixth and seventh on the Illumigene platform, which is based on loop-mediated isothermal amplification. Illumigene CT and NG use endocervical swabs, self-collected vaginal swabs, and female and male urine, making collection easy and non-invasive, Meridian said. The tests take less than one hour to perform, and require no expensive capital equipment, the company also noted.

Illumigene also said that it received the CE mark for M-prep, a sample preparation system designed to facilitate the isolation of C. trachomatis and N. gonorrhoeae from clinical samples.

All three new products will be distributed in Europe, the Middle East, and Africa by Meridian Bioscience Europe and in additional international markets through distributors.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.